Psyllium Husks
Natural health product licensed in Canada
- Licence holder
- 1123573 BC Ltd.
- NPN or DIN-HM
- 80006291
- Status
- Active licence
- Licence date
- 25 June 2008
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Gélatine, Dioxyde de silicium, Stéarate de magnésium, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 6 Capsule ; maximum: 8 Capsule | 3 Tous les jours |
Uses authorised in Canada
A bulk-forming Laxative.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Do not use if you are pregnant or diabetic. Do not use if you suffer intestinal tract blockage or hardening of the esophagus or gastrointestinal tract. Do not take with any other medicine within 2 hours of taking psyllium husks. If allergies occur discontinue use. Do not use in the presence of abdominal pain, nausea, fever or vomiting. Do not take any type of laxative for more than a week, unless your physician has ordered a special schedule for you.
Source
Official Health Canada record, licence 80006291
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.